Literature DB >> 3160725

Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma. Characterization of this immunoglobulin.

L L Kilgore, B W Patterson, D M Parenti, W R Fisher.   

Abstract

An antibodylike paraprotein has been isolated from a patient with multiple myeloma and autoimmune hyperlipoproteinemia. The paraprotein bound to apolipoprotein B (apo B)-containing lipoproteins that formed macromolecular aggregates, and globules thought to be aggregated complexes of lipoproteins and reactive immunoglobulins were observed circulating within the retinal blood vessels of this patient. This binding specificity permitted purification of the paraprotein from both the agglutinated immune complexes and from the plasma. The protein is an IgA, kappa-immunoglobulin which exists primarily in a polymeric state. Capillary immunoprecipitation demonstrated reactivity with very low density lipoproteins (VLDL) and low density proteins (LDL), but not with high density lipoproteins (HDL). Delipidated apo B and apo E, but not apo A or apo C, formed precipitates with this immunoglobulin. In using a radioimmunoassay format, the affinity of the immunoglobulin was greatest for VLDL and decreases sequentially for intermediate density lipoproteins and LDL. No binding occurred with a dispersion of LDL lipids or with HDL. Deglycosylation did not change the binding to LDL. The apolipoproteins B and E bound with similar affinity, but no binding occurred with apo A-I or apo A-II. Weak binding appeared to occur with apo C. This paraprotein immunoprecipitated apo B-containing lipoproteins from all classes of vertebrates tested. Displacement of the lipids of LDL by Triton X-100 resulted in the formation of an apo B-Triton complex which, however, did not bind to the immunoglobulin; apparently the binding site on apo B was lost. Upon enzymatic digestion with the IgA-specific protease from Streptococcus sanguis the immunoglobulin was cleaved into Fc and Fab fragments, and the binding of LDL occurred only with the latter, consistent with the behavior of an immunoglobulin. The immunoreactivity of this paraprotein with apo B and apo E raises the interesting possibility that it may be binding to a site on these apolipoproteins which is reactive with the apo B, E receptor of the plasma membrane, a site which is conserved throughout the vertebrate phylum.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160725      PMCID: PMC423752          DOI: 10.1172/JCI111951

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Ultracentrifugal analysis of serum lipoproteins.

Authors:  O F DE LALLA; J W GOFMAN
Journal:  Methods Biochem Anal       Date:  1954

2.  Solubilization of apolipoprotein B and its specific binding by the cellular receptor for low density lipoprotein.

Authors:  R Shireman; L L Kilgore; W R Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

3.  Fractionation of the C-apoproteins from human plasma very low density lipoproteins.

Authors:  P N Herbert; R S Shulman; R I Levy; D S Fredrickson
Journal:  J Biol Chem       Date:  1973-07-25       Impact factor: 5.157

4.  The size and number of polypeptide chains in human serum low density lipoprotein.

Authors:  R Smith; J R Dawson; C Tanford
Journal:  J Biol Chem       Date:  1972-06-10       Impact factor: 5.157

5.  Size heterogeneity of human IgA myeloma proteins. Relationships between polymers and "J" chain.

Authors:  J M Fine; P Lambin; D Frommel
Journal:  Biomedicine       Date:  1973-03

6.  Crystalline IgG protein in multiple myeloma: identification effects on coagulation and on lipoprotein metabolism.

Authors:  H I Glueck; M R MacKenzie; C J Glueck
Journal:  J Lab Clin Med       Date:  1972-05

7.  Selective enzyme purification by affinity chromatography.

Authors:  P Cuatrecasas; M Wilchek; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

8.  Autoimmune hyperlipidemia.

Authors:  J L Beaumont; V Beaumont
Journal:  Atherosclerosis       Date:  1977-04       Impact factor: 5.162

9.  Cholesterol dynamics in autoimmune hyperlipidemia.

Authors:  K J Ho; V G de Wolfe; W Siler; L A Lewis
Journal:  J Lab Clin Med       Date:  1976-11

10.  Plane xanthoma and multiple myeloma with lipoprotein--paraprotein complexing.

Authors:  J S Taylor; L A Lewis; J D Battle; A Butkus; A L Robertson; S Deodhar; H H Roenigk
Journal:  Arch Dermatol       Date:  1978-03
View more
  6 in total

Review 1.  The antiphospholipid syndrome and atherosclerosis: clue to pathogenesis.

Authors:  Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

Review 2.  What causes the antiphospholipid syndrome?

Authors:  J T Merrill
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

3.  Autoantibodies to the low density lipoprotein receptor in a subject affected by severe hypercholesterolemia.

Authors:  A Corsini; P Roma; D Sommariva; R Fumagalli; A L Catapano
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

4.  Cutaneous xanthoma in association with paraproteinemia in the absence of hyperlipidemia.

Authors:  K R Feingold; G R Castro; Y Ishikawa; P E Fielding; C J Fielding
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

5.  Atypical type III hyperlipoproteinemia in a patient with Ig A myelomatosis.

Authors:  G Feussner; E von Hodenberg; R Ziegler
Journal:  Klin Wochenschr       Date:  1990-05-17

Review 6.  Metabolic Disorders in Multiple Myeloma.

Authors:  Maria Gavriatopoulou; Stavroula A Paschou; Ioannis Ntanasis-Stathopoulos; Meletios A Dimopoulos
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.